|
Video: What is a Stock Split?
|
|
Hepion Pharmaceuticals is a biopharmaceutical company focused primarily on the clinical development and commercialization of targeted antiviral therapies with a specific focus on developing a potentially curative therapy for hepatitis B virus (HBV). Co. is developing two anti-HBV compounds with complementary mechanisms of action. Co.'s key compound, TXL is in development and is designed to deliver high intrahepatic concentrations of tenofovir (TFV), while minimizing off-target effects caused by high levels of circulating TFV. CRV431, Co.'s second compound for HBV, is a next-generation cyclophilin inhibitor with a structure that increases its selective index against TXL. According to our CTRV split history records, CTRV has had 2 splits. | |
|
CTRV (CTRV) has 2 splits in our CTRV split history database. The first split for CTRV took place on May 29, 2018. This was a 1 for 8 reverse split, meaning for each 8 shares of CTRV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 125 share position following the split. CTRV's second split took place on June 03, 2019. This was a 1 for 70 reverse split, meaning for each 70 shares of CTRV owned pre-split, the shareholder now owned 1 share. For example, a 125 share position pre-split, became a 1.78571428571429 share position following the split.
When a company such as CTRV conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CTRV split history from start to finish, an original position size of 1000 shares would have turned into 1.78571428571429 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CTRV shares, starting with a $10,000 purchase of CTRV, presented on a split-history-adjusted basis factoring in the complete CTRV split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/04/2014 |
|
End date: |
07/22/2019 |
|
Start price/share: |
$672.00 |
|
End price/share: |
$3.58 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.47% |
|
Average Annual Total Return: |
-67.07% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$53.30 |
|
Years: |
4.71 |
|
|
|
Date |
Ratio |
05/29/2018 | 1 for 8 | 06/03/2019 | 1 for 70 |
|
|